← Back to search

Voyage Biomedical

Using cooling to end brain damage during stroke.

Y CombinatorSummer 2019AcquiredHealthcareMedical DevicesHardwareNeurotechnologyMedical Devices

What they do

Problem

Stroke patients often suffer preventable brain damage due to lack of effective neuroprotection during and immediately after ischemic events.

Solution

It develops therapeutic cooling technology to rapidly lower brain temperature to protect neural tissue during stroke.

Who it's for

Neurovascular clinicians and hospitals treating acute stroke patients.

Founders

Justin Olshavsky
Founder

Founder of Voyage Bio (S19, acquired by Penumbra), founding partner of Pioneer Bio+Health Fund

Robert Schultz
Founder

MD, heart surgery resident

Bridget Vaughan
Founder

Company timeline

Similar startups